Navigation Links
Novartis to Expand Global Research Headquarters in Cambridge, MA
Date:10/27/2010

to the dynamic life sciences climate here."

Since 2002 Novartis has steadily grown its operations in Cambridge. Today the company employs more than 2,000 associates and occupies more than 1 million square feet of laboratory and office space -- making it the city's largest corporate employer.  The company's operations in Cambridge include the global headquarters for the Novartis Institutes for BioMedical Research; Novartis Molecular Diagnostics, a dedicated business unit focused on developing tests to advance patient tailored treatment; Novartis Vaccines and Diagnostics, a division focused on providing vaccines and diagnostic tools to prevent diseases and protect societies worldwide, and the U.S. office of the Novartis Venture Funds.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "to expand," "will," "expected," "look forward to," "plans," "commitment," or similar expressions, or by express or implied discussions regarding potential future approvals of new medicines developed or to be developed by the Novartis Institutes for BioMedical Research, or regarding potential future revenues from such medicines. You should not place undue reliance on these statements.  Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any new medicines developed or to be developed by the Novartis Institutes for BioMedical Research will be submitted or approved for sale in any market. Nor can there be any guarantee that any such medicines will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these medicines could be affected by, among other things, un
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Kiromic, LLC, a ... of Kent Hance , the former chancellor of Texas ... retired as chancellor in July 2014, after raising $1.2 billion ... that Kent Hance , the most successful chancellor in ... team not only as an investor, but also as our ...
(Date:9/19/2014)... , September 19, 2014 ... by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, ... (Hospitals), Advanced technologies - Global Forecast to 2019" ... poised to reach $19,786.3 Million by 2019 from ... 6.8% from 2014 to 2019. Browse ...
(Date:9/19/2014)... , Sept. 19, 2014  4WEB Medical announces ... 3D-printed foot and ankle osteotomy implants on the ... Ankle Society annual meeting in Chicago ... all of a surgeon,s osteotomy needs with 74 size options ... systems had smaller offerings of only 15 to 18 implant ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
... ... pay the United States $1.375 million to resolve False Claims Act ... of a sham durable medical equipment (DME) provider, the Justice Department ... MediNet Corp. provided the kickbacks and assistance and, in return, Harborside ...
... Industry Distributors Association (HIDA) announces the launch of a ... value of medical products distribution. , "Nearly one hundred ... delivered by a distributor, yet few people understand the ... it more efficient," said Matthew J. Rowan, HIDA,s president ...
Cached Medicine Technology:Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services 2
(Date:9/21/2014)... While public health authorities focus on the physical activity ... University of Montreal reveals that for children, playing has ... an activity that is fun, done alone or with ... or pleasure, but also to combat boredom, sadness, fear, ... of play, authorities put aside several aspects of play ...
(Date:9/21/2014)... roasted peanuts are more likely to trigger an allergy ... study involving mice. , The researchers say that specific ... dry roasting process are recognised by the body,s immune ... immune response the next time it sees any peanuts. ... number of people with peanut allergies in the Western ...
(Date:9/21/2014)... The Laboratory Testing Services industry is ... tests on items ranging from consumer and food products ... on operators to ensure the safety and quality of ... of government safety regulations and consumer lawsuits have led ... Although revenue briefly dipped in 2009 as the US ...
(Date:9/21/2014)... "I wanted to be able to obtain a ... energy drinks," said an inventor from Fresh Meadows, N.Y. ... plain, old coffee. That is why I came up ... CHEWING GUM to provide a healthy energy boost that ... nutritious vitamins, minerals and antioxidants. It also features a ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 The ... BHWG) will host a statewide symposium ( tinyurl.com/ILBHC14 ... Veterans, and their Families. Sponsored by the VNA ... Lottery Cash Grant, and Health & Disability Advocates, ... at the Hilton Hotel in Springfield, IL. ...
Breaking Medicine News(10 mins):Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:Dry roasting could help trigger peanut allergy 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3
... LUNA and the Breast Cancer Fund Launch National Campaign to Inspire ... Educate that Prevention is ... be diagnosed with breast cancer in their lifetime. Although 50 percent,of ... sufferers have a genetic history of the disease. LUNA, the ...
... Mich., Oct. 29 American,Physicians Capital, Inc. (Nasdaq: ... has authorized the repurchase of an additional $20,million of ... under Rule 10b5-1,of the Securities Exchange Act of 1934. ... dollars allocated to the 2007 10b5-1 plan,adopted by the ...
... to Ongoing Oncology Program for MDX-1106, PRINCETON, ... Medarex, Inc. (Nasdaq: MEDX ) announced today ... filed with the U.S. Food &,Drug Administration (FDA) ... Ltd.), a fully human anti-PD-1 antibody being,investigated for ...
... the 2007 third quarter includes $1.8 million of first ... commercial products, DUBLIN, Calif., Oct. 29 SuperGen ... the discovery, rapid,development and commercialization of therapies for solid ... third,quarter and nine months ended September 30, 2007. ...
... with first-ever attack, babies, and people with AIDS, guideline ... CT brain scans should be used to screen certain ... the right kind of treatment, according to a new ... The guideline authors analyzed all available scientific evidence on ...
... for evaluating the eyes ability to distinguish object details ... could provide a more accurate way to assess the ... devices and training, according to a Canadian study. The ... illumination targets for testing spatial vision, which the authors ...
Cached Medicine News:Health News:LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions 2Health News:LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions 3Health News:American Physicians Capital, Inc. Authorizes Additional $20 Million Share Buyback 2Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 2Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 3Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 4Health News:SuperGen Reports 2007 Third Quarter Financial Results 2Health News:SuperGen Reports 2007 Third Quarter Financial Results 3Health News:SuperGen Reports 2007 Third Quarter Financial Results 4Health News:SuperGen Reports 2007 Third Quarter Financial Results 5Health News:SuperGen Reports 2007 Third Quarter Financial Results 6Health News:SuperGen Reports 2007 Third Quarter Financial Results 7Health News:SuperGen Reports 2007 Third Quarter Financial Results 8Health News:SuperGen Reports 2007 Third Quarter Financial Results 9Health News:SuperGen Reports 2007 Third Quarter Financial Results 10Health News:Certain Seizure Patients Need Emergency CT Scan 2Health News:Test for visual acuity could aid detection, rehabilitation of AMD 2
... Design Holds The Lens Securely During ... Blades Keep The Optic From Being ... Over Release Of The Optic.,Wide Jaw ... During Insertion.,Reusable, Autoclaveable, Made In The ...
... Unique In-Line Footplates Are Turned 90 ... The Diamond Blade While Incising Tissue. ,Special ... Blade Depth Penetration.,Pre-Set Blade Extension Settings ... Retraction And Full Extension.,1mm Wide Snub ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Pocket-sized instrument with 2.5X magnification....
Medicine Products: